Revolutionary £50M Partnership: GSK and Oxford Race to Develop Cancer-Preventing Vaccines
30 Jan 2025
In a groundbreaking move that could revolutionize the future of cancer prevention, GlaxoSmithKline (GSK) has announced a £50 million investment in a collaborative project with the University of Oxford aimed at developing cancer vaccines. This partnership marks a significant step forward in the fight against cancer, as scientists are exploring...
Read More
